Penn Medicine Abramson Cancer Center


 

UPenn ASH Highlights on PI3Ki & BTKi for R/R MZL: How Effective Are Parsaclisib & Zanubrutinib?

70 views
March 2, 2021
0 Comments
Login to view comments. Click here to Login
New Therapies and Current Patient Management of Lymphomas